Tyra Biosciences, Inc.
TYRA
$10.09
$0.020.20%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -96.44M | -86.48M | -83.74M | -80.88M | -75.45M |
| Total Depreciation and Amortization | 540.00K | 519.00K | 477.00K | 433.00K | 396.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 19.59M | 16.92M | 14.34M | 12.75M | 12.73M |
| Change in Net Operating Assets | 3.11M | -729.00K | 5.21M | 4.73M | -1.00K |
| Cash from Operations | -73.20M | -69.77M | -63.72M | -62.96M | -62.32M |
| Capital Expenditure | -542.00K | -664.00K | -1.26M | -1.29M | -865.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -83.91M | -97.74M | -248.54M | -270.15M | -125.63M |
| Cash from Investing | -84.45M | -98.40M | -249.80M | -271.44M | -126.49M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 4.26M | 202.56M | 202.18M | 201.90M | 201.65M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -251.00K | -420.00K | -420.00K | -420.00K | -169.00K |
| Cash from Financing | 4.01M | 202.14M | 201.76M | 201.48M | 201.48M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -153.65M | 33.96M | -111.76M | -132.92M | 12.67M |